title: ERasing breast cancer resistance through the kinome.
authors.forename: Amber B
authors.initials: AB
authors.lastname: Johnson
authors.forename: Bert W
authors.initials: BW
authors.lastname: O'Malley
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D019008:Drug Resistance, Neoplasm / Q000187:drug effects / Q000502:physiology*; D047628:Estrogen Receptor alpha / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006801:Humans; D008565:Membrane Proteins / Q000494:pharmacology*; D017346:Protein Serine-Threonine Kinases / Q000494:pharmacology*; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D008565:Membrane Proteins; D013629:Tamoxifen; C560359:LMTK3 protein, human; D017346:Protein Serine-Threonine Kinases